Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Total Valuation
Elevance Health has a market cap or net worth of $72.89B. The enterprise value is $99.10B.
Market Cap$72.89B
Enterprise Value$99.10B
Share Statistics
Elevance Health has 220,704,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding220,704,670
Owned by Insiders0.14%
Owned by Institutions11.04%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.38%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)8.38%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee1.91M
Profits Per Employee54.33K
Employee Count104,200
Asset Turnover1.64
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 13.1. Elevance Health’s PEG ratio is -5.63.
PE Ratio13.1
PS Ratio0.39
PB Ratio1.77
Price to Fair Value1.77
Price to FCF24.50
Price to Operating Cash Flow17.93
PEG Ratio-5.63
Income Statement
In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.
Revenue199.13B
Gross Profit50.90B
Operating Income8.11B
Pretax Income6.71B
Net Income5.66B
EBITDA9.66B
Earnings Per Share (EPS)25.18
Cash Flow
In the last 12 months, operating cash flow was 4.29B and capital expenditures -1.12B, giving a free cash flow of 3.17B billion.
Operating Cash Flow4.29B
Free Cash Flow3.17B
Free Cash Flow per Share14.38
Dividends & Yields
Elevance Health pays an annual dividend of $1.71, resulting in a dividend yield of 1.99%
Dividend Per Share$1.71
Dividend Yield1.99%
Payout Ratio22.29%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change-13.52%
50-Day Moving Average350.22
200-Day Moving Average340.98
Relative Strength Index (RSI)40.85
Average Volume (3m)1.60M
Important Dates
Elevance Health upcoming earnings date is Apr 22, 2026, Before Open (Confirmed).
Last Earnings DateJan 28, 2026
Next Earnings DateApr 22, 2026
Ex-Dividend Date―
Financial Position
Elevance Health as a current ratio of 1.54, with Debt / Equity ratio of 73.03%
Current Ratio1.54
Quick Ratio1.54
Debt to Market Cap0.41
Net Debt to EBITDA2.34
Interest Coverage Ratio5.79
Taxes
In the past 12 months, Elevance Health has paid 1.05B in taxes.
Income Tax1.05B
Effective Tax Rate0.16
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 10.39, with an EV/FCF ratio of 31.60.
EV to Sales0.50
EV to EBITDA10.39
EV to Free Cash Flow31.60
EV to Operating Cash Flow23.38
Balance Sheet
Elevance Health has $9.49B in cash and marketable securities with $32.05B in debt, giving a net cash position of -$22.55B billion.
Cash & Marketable Securities$9.49B
Total Debt$32.05B
Net Cash-$22.55B
Net Cash Per Share-$102.20
Tangible Book Value Per Share-$30.29
Margins
Gross margin is 25.56%, with operating margin of 4.07%, and net profit margin of 2.84%.
Gross Margin25.56%
Operating Margin4.07%
Pretax Margin3.37%
Net Profit Margin2.84%
EBITDA Margin4.85%
EBIT Margin4.07%
Analyst Forecast
The average price target for Elevance Health is $389.07, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$389.07
Price Target Upside17.81% Upside
Analyst ConsensusModerate Buy
Analyst Count15
Revenue Growth Forecast11.96%
EPS Growth Forecast-11.11%